文献速递胰腺与胆道疾病消化内镜消化道肿瘤与早癌

探头式共聚焦激光显微内镜评估原发性硬化性胆管炎主导性狭窄:美国多中心前瞻性试验

Probe-based confocal laser endomicroscopy in the evaluation of dominant strictures in patients with primary sclerosing cholangitis: results of a U.S. multicenter prospective trial.
PubMed 文献 · Gastrointest Endosc · 2021-03-30

该多中心前瞻性研究纳入59例原发性硬化性胆管炎(PSC)伴主导性狭窄患者(63处狭窄),评估探头式共聚焦激光显微内镜(pCLE)的诊断性能。结果显示pCLE检测胆管癌的敏感性为85.7%(95%CI 42.1-99.6),特异性为73.1%(95%CI 58.9-84.4);但胆总管和左肝管狭窄的敏感性较低。

要点

  • pCLE对PSC主导性狭窄相关胆管癌的敏感性为85.7%,特异性为73.1%。
  • 胆管分叉部和右肝管狭窄的pCLE敏感性最高,均为100%。
  • 胆总管和左肝管狭窄的pCLE敏感性较低,分别为25%和28.6%。

核心结论

  • pCLE检测胆管癌具有高敏感性,但探头技术因素可能限制胆总管和左肝管的评估。

研究设计与样本

  • 多中心前瞻性研究,纳入59例PSC伴主导性狭窄患者(63处狭窄),平均年龄49岁,59%为男性。
  • ERCP下进行pCLE,采用Miami分类(2条及以上标准诊断为恶性)和Paris分类。
  • 最终恶性诊断需组织病理学确认,良性诊断需至少1年随访无癌症发生。

主要发现

  • 7例患者(11.9%)发现胆管癌。
  • pCLE敏感性85.7%(95%CI 42.1-99.6),特异性73.1%(95%CI 58.9-84.4)。
  • 狭窄部位包括胆总管(31.7%)、分叉部(22.2%)和肝总管(19%)。
  • 分叉部敏感性100%(95%CI 2.5-100),右肝管敏感性100%(95%CI 29.2-100)。
  • 胆总管敏感性25%(95%CI 5.5-57.2),左肝管敏感性28.6%(95%CI 3.7-70.9)。

关键数值与推荐

  • Miami分类:2条及以上标准诊断为恶性。
  • 最终恶性诊断需组织病理学确认,良性诊断需至少1年随访无癌症发生。

临床怎么用

  • pCLE可作为PSC主导性狭窄排除肿瘤的辅助手段,但需注意胆总管和左肝管狭窄的评估限制。
  • pCLE在PSC主导性狭窄诊断流程中的作用尚需进一步研究明确。

局限性

  • 探头技术因素可能限制胆总管和左肝管的评估。
  • 样本量较小,部分部位敏感性置信区间宽。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Patients with primary sclerosing cholangitis (PSC) and dominant biliary strictures carry increased risk for the development of cholangiocarcinoma. Although ERCP-based techniques including brush cytology and intraductal biopsy sampling represent first-line tissue sampling methods for dominant strictures, sensitivity is low. Probe-based confocal laser endomicroscopy (pCLE) offers microscopic-level imaging of subepithelial biliary mucosa. Because data regarding the use of pCLE in PSC are limited, we aimed to investigate its diagnostic performance in dominant strictures. METHODS: This was a multicenter prospective study involving PSC patients with dominant strictures. ERCP with pCLE was performed with use of the Miami classification (2+ criteria for malignant diagnosis) and Paris classification. Final malignant diagnoses required histopathologic confirmation, and benign diagnoses required a minimum of 1 year of follow-up without development of cancer. RESULTS: Fifty-nine patients (mean age, 49 years; 59% men) with 63 strictures were included in the study. Stricture locations included the common bile duct (31.7%), bifurcation (22.2%), and common hepatic duct (19%). Seven patients (11.9%) were found to have cholangiocarcinoma. The sensitivity and specificity of pCLE was 85.7% (95% confidence interval [CI], 42.1-99.6) and 73.1% (95% CI, 58.9-84.4), respectively. Within specific stricture locations, the highest sensitivity was seen at the bifurcation (100%; 95% CI, 2.5-100) and the right hepatic duct (100%; 95% CI, 29.2-100). The lowest sensitivities were seen at the common bile duct (25%; 95% CI, 5.5-57.2) and the left hepatic duct (28.6%; 95% CI, 3.7-70.9). CONCLUSIONS: In this prospective multicenter study, pCLE had a high sensitivity in detecting cholangiocarcinoma, but technical aspects of the probe may limit evaluation in the common bile duct and left hepatic duct. Further evaluation is needed to elucidate the role of pCLE in the algorithm of excluding neoplasia in biliary strictures associated with PSC. (Clinical trial registration number: NCT02736708.).

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Han S, Kahaleh M, Sharaiha RZ, et al. Probe-based confocal laser endomicroscopy in the evaluation of dominant strictures in patients with primary sclerosing cholangitis: results of a U.S. multicenter prospective trial. Gastrointest Endosc. 2021. PMID: 33798541. doi:10.1016/j.gie.2021.03.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。